Physician profile

Frederick L Durden

Plastic Surgery · Newnan, GA

NPI 1073799490

$2,121.11

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$24.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Rti Surgical, INC $1,000.00 2022
Surgalign Spine Technologies, INC. $826.73 2019
Tela Bio, INC. $99.35 2022
Ethicon US, LLC $70.53 2019-2021
Medtronic, INC. $28.20 2021
Smith+Nephew, INC. $24.20 2023 Grafix
Allergan, INC. $23.45 2020
Zimmer Biomet Holdings, INC. $19.14 2022
Janssen Biotech, INC. $14.97 2019
Astrazeneca Pharmaceuticals LP $14.54 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Frederick L Durden

$2,121.11

in general payments reported 2019-2025

Years
2019-2023
Top company
Rti Surgical, INC

https://glasscript.com/doctor/4211/frederick-l-durden

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.